We have compared the pattern of surface antigen expression, as detected by monoclonal antibodies (mAbs), in plasma membranes vs shed membrane vesicles of two human breast carcinoma cell lines, MCF-7 and 8701-BC. Antigen expression was detected on cells by immunofluorescence (IF) analysis, whilst, due to their small dimensions, the same technique was not applicable to vesicles. For these structures dot-blot analysis and immunoelectron microscopy (IEM) were employed. When applicable, both cell membranes and membrane vesicles were immunoprecipitated and the precipitate (IP) was analyzed by SDS-PAGE. Cells of both lines expressed HLA class I antigens, epithelial cytokeratins, β1 integrins, CEA and the glycoprotein detected by mAb 19.9, but only MCF-7 cells expressed Lewis Y, episialin and globo-H antigens and only 8701-BC cells expressed folate receptor. Membrane vesicles of both cell lines appeared to be rich in β1, α3 and α5 integrin chains, expressed HLA class I antigens and carried most of the plasma membrane antigens found in the cell membranes. Overall we have analyzed 17 antigens on the two cell lines and on their vesicles. The results obtained for cells (IF and IP) and those for vesicles (dot-blot and IP) were generally concordantly positive or concordantly negative. We obtained a total of 26 clearly concordant combinations on 34 analyses. In three cases we found discordant results, whereas in the remaining combinations we observed slight reactivity and we found difficulties in determining concordance. Discordant results concerned the expression of the following antigens: folate receptors, which were clearly expressed in 8701-BC cells but not detected by dot-blot analysis or IEM on their shed membrane vesicles; neu (c-erb-B2) receptor found in MCF-7 cell membranes but not in their vesicles; and the globo-H antigen recognized by mAb MBr1, detected at low levels on 8701-BC plasma membranes but undetectable on their membrane vesicles. Like vesicles shed in vitro by cultured cells, the vesicles shed in vivo by human breast carcinoma cells could be tagged with several antibodies against tumor-associated antigens. The vesicles shed in vivo were found in association with a fiber network. Some of the fibers had the characteristic fibrin periodicity. These data suggest that tumor markers detected in the circulation of carcinoma patients, at least in part, are carried by shed membrane vesicles. Moreover the observation that membrane vesicles carry both tumor-associated antigens and HLA class I molecules indicate that these structures could in principle present antigens to the immune system. Together with our previous demonstration that membrane vesicles shed by breast carcinoma cells contain TGF-β, these results suggest an important role for vesicles in the immunological escape of these cells. The presence in membrane vesicles of integrins, together with the previous observation that they are rich in gelatinolytic activities, also points to a possible role of these structures in the metastatic behavior of tumor cells.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Taylor, DD and Black, PH, 1986, Shedding of plasma membrane fragments. Neoplastic and developmental importance. In: Steinberg, M, ed. Developmental Biology, 3, pp. 33–57. New York: Plenum Press.
Taylor, DD, Taylor, CG, Jiang, CG and Black, PH, 1988, Characterization of plasma membrane shedding from murine melanoma cells. Int J Cancer, 41, 629–35.
Poste, G and Nicolson, GL, 1980, Arrest and metastasis of blood-borne tumor cells are modified by fusion of plasma membrane vesicles from highly metastatic cells. Proc Natl Acad Sci USA, 77, 399–403.
Zucker, S, Wieman, JM, Lysik, RM et al., 1987, Metastatic mouse melanoma cells release collagengelatin degrading metalloproteinases as components of shed membrane vesicles. Biochim Biophys Acta, 924, 225–37.
Murayama, T, Kataoka, H, Koita, H, Nabeshima, K and Koono, M, 1991, Glycocaliceal bodies in a human rectal carcinoma cell line and their interstitial collagenolytic activities. Virchows Arch B Cell Pathol, 60, 263–70.
Dolo, V, Ginestra, A, Ghersi, G, Nagase, H and Vittorelli, ML, 1994, Human breast carcinoma cells cultured in the presence of serum shed membrane vesicles rich in gelatinolytic activities. J Submicrosc Cytol Pathol, 26, 173–80.
Minafra, S, Morello, V, Glorioso, F et al., 1989, A new cell line (8701-BC) from primary ductal infiltrating carcinoma of human breast. Br J Cancer, 60, 185–92.
Kern, FG, McLeskey, SW et al., 1994, Transfected MCF-7 cells as a model for breast cancer progression. Breast Cancer Res Treat, 31, 153–65.
Bradford, MM, 1976, A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-day binding. Anal Biochem, 72, 248–54.
Laemmli, UK, 1970, Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, 227, 680–5.
Makin, CA, Bobrow, LG, Bodmer, WF,1982, Monoclonal antibody to cytokeratin for use in routine histopathology. J Clin Pathol, 37, 975–983.
Brodsky, FM and Parham, P. 1982, Monomorphic anti-HLA-A, B, C monoclonal antibodies detecting molecular subunits and combinatorial determinants. J Immunol, 128, 129–35.
Ménard, S, Tagliabue, E, Canevari, S, Fossati, G and Colnaghi, MI, 1983, Generation of monoclonal antibodies reacting with normal and cancer cells of human breast. Cancer Res, 43, 1295–300.
Dejana, E, Martin-Padura, I, Lauri, D et al., 1992, Endothelial leukocyte adhesion molecule-1-dependent adhesion of colon carcinoma cells to vascular endothelium is inhibited by an antibody to Lewis fucosylated type 1 carbohydrate chain. Lab Invest, 66, 324–30.
Leoni, F, Colnaghi, MI, Canevari, S et al., 1992, Glycolipids carrying Ley are preferentially expressed on small-cell lung cancer cells as detected by the monoclonal antibody MLuC1. Int J Cancer, 51, 225–31.
Mastroianni, A, Tagliabue, E, Centis, F et al., 1992, Study of a soluble tumor-associated marker composed of CEA related molecules recognized by three monoclonal antibodies. Int J Biol Markers, 7, 21–6.
Van de Wiel-van Kemenade, E, Ligtenberg, MJL, De Boer, AJ et al., 1993, Episialin (MUC1) inhibits cytotoxic lymphocyte-target cell interaction. J Immunol, 151, 767–76.
Larson, SM, 1993, A model for others: A strategy for improving diagnosis and therapy of human malignancies using monoclonal antibodies targeting TAG-72 oncofetal antigen. Cancer Invest, 11, 235–38.
Magnani, JL, Steplewski, Z, Koprowski, H, and Ginsburg, V, 1983, Identification of the gastrointestinal and pancreatic cancer-associated antigen detected by monoclonal antibody 19–9 in the sera of patients as a mucin. Cancer Res, 43, 5489–92.
Miotti, S, Canevari, S, Ménard, S, Mezzanzanica, D, Porro, G et al., 1987, Characterization of human ovarian carcinoma-associated antigens defined by novel monoclonal antibodies with tumor-restricted specificity. Int J Cancer, 39, 297–303.
Gadina, M, Tosi, E, Benigni, F et al., 1993, Derivatization and pharmacokinetics of an anti-EGF-R mAb and the RIP α-sarcin in the perspective of immunoconjugate generation. In: Epenetos, AA, ed. Monoclonal Antibodies: Applications in Clinical Oncology. London: Chapman & Hall Medical, pp. 473–9.
Centis, F, Tagliabue, E, Uppugunduri, S, et al., 1992, p185 HER2/neu epitope mapping with murine monoclonal antibodies. Hybridoma, 11, 267–76.
Della Torre, G, Canevari, S, Orlandi, R and Colnaghi, MI, 1987, Internalization of a monoclonal antibody against human breast cancer by immunoelectron microscopy. Br J Cancer, 55, 357–9.
Pellegrini, R, Bazzini, P, Tosi, E et al., 1992, Production and characterization of two monoclonal antibodies directed against the integrin β1 chain. Tumori, 78, 1–4.
Wayner, E.A, Carter, WG, Piotrowicz, RS and Kunicki, TJ, 1988, The function of multiple extracellular matrix receptors in mediating cell adhesion to extracellular matrix: preparation of monoclonal antibodies to the fibronectin receptor that specifically inhibit cell adhesion to fibronectin and react with platelet glycoproteins Ic–IIa. J Cell Biol, 107, 1881–91.
Bottini, C, Miotti, S, Fiorucci, S et al., 1993, Polarization of the α6β4 integrin in ovarian carcinomas. Int J Cancer, 54, 261–7.
Svanberg, L and Astedt, B, 1975, Coagulative and fibrinolytic properties of ascitic fluid associated with ovarian tumors. Cancer, 35, 1382–7.
Lerner, MP, Lucid, SW, Wen, GI and Nordquist, RE, 1983, Selected area membrane shedding by tumor cells. Cancer Lett, 20, 125–30.
Van Blitterswijk, WJ, De Veer, G, Krol, JH and Emmelot, P, 1982, Comparative lipid analysis of purified plasma membranes and shed extracellular membrane vesicles from normal murine thymocytes and leukaemia GRSL cells. Biochim Biophys Acta, 688, 496–504.
Barz, D, Goppelt, M, Szamel, M, Schirrmacher, V and Resch, K, 1985, Characterization of cellular and extracellular plasma membrane vesicles from a non-metastasizing lymphoma (Eb) and its metastasizing variant. Biochim Biophys Acta, 814, 77–84.
Dvorak, HF, Quay, SC, Orenstein, NS et al. 1981, Tumor shedding and coagulation. Science, 212, 923–4.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Dolo, V., Adobati, E., Canevari, S. et al. Membrane vesicles shed into the extracellular medium by human breast carcinoma cells carry tumor-associated surface antigens. Clin Exp Metast 13, 277–286 (1995). https://doi.org/10.1007/BF00133483
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00133483